These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
496 related items for PubMed ID: 2982089
1. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M, Stenstrom S, Richelson E. Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089 [Abstract] [Full Text] [Related]
2. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation. McKinney M, Stenstrom S, Richelson E. Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690 [Abstract] [Full Text] [Related]
3. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation. McKinney M, Richelson E. Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477 [Abstract] [Full Text] [Related]
4. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. Cioffi CL, el-Fakahany EE. J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226 [Abstract] [Full Text] [Related]
5. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition. McKinney M, Miller JH, Gibson VA, Nickelson L, Aksoy S. Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002 [Abstract] [Full Text] [Related]
6. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems. McKinney M, Anderson D, Vella-Rountree L. Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467 [Abstract] [Full Text] [Related]
7. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. el-Fakahany EE, Surichamorn W, Amrhein CL, Stenstrom S, Cioffi CL, Richelson E, McKinney M. J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677 [Abstract] [Full Text] [Related]
8. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells. Brown JH, Goldstein D, Masters SB. Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122 [Abstract] [Full Text] [Related]
9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M, Waelbroeck M, Christophe J. Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [Abstract] [Full Text] [Related]
10. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells. Lai WS, el-Fakahany EE. J Pharmacol Exp Ther; 1987 May; 241(2):366-73. PubMed ID: 3033212 [Abstract] [Full Text] [Related]
12. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. Michal P, Lysíková M, Tucek S. Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872 [Abstract] [Full Text] [Related]
13. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Fisher SK. Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485 [Abstract] [Full Text] [Related]
14. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation. Meeker RB, Harden TK. Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648 [Abstract] [Full Text] [Related]
15. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Evans T, Smith MM, Tanner LI, Harden TK. Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892 [Abstract] [Full Text] [Related]
16. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. Brown JH, Goldstein D. Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810 [Abstract] [Full Text] [Related]
17. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function. Feigenbaum P, El-Fakahany EE. J Pharmacol Exp Ther; 1985 Apr; 233(1):134-40. PubMed ID: 3981451 [Abstract] [Full Text] [Related]
18. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. Akiyama K, Vickroy TW, Watson M, Roeske WR, Reisine TD, Smith TL, Yamamura HI. J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550 [Abstract] [Full Text] [Related]
19. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells. Mei L, Lai J, Roeske WR, Fraser CM, Venter JC, Yamamura HI. J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406 [Abstract] [Full Text] [Related]
20. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC, Maullu C, Onali P. Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]